Clinical Report: Link Between Duration of Dysphagia and Dysphonia and Insomnia
Overview
This study analyzes the 2022 National Health Interview Survey data to explore the relationship between the durations of dysphagia and dysphonia and the incidence of insomnia. Findings indicate that both dysphagia and dysphonia durations are independent risk factors for insomnia.
Background
Insomnia is a prevalent sleep disorder that significantly impacts health and quality of life, affecting approximately 10% of adults. Understanding the risk factors associated with insomnia is crucial for effective intervention and management. Dysphagia and dysphonia, often overlooked, may contribute to insomnia through various physiological and psychological mechanisms.
Both conditions are identified as independent risk factors for insomnia (OR > 1, p < 0.05).
The association between dysphagia/dysphonia and insomnia remains significant after adjusting for covariates.
Dysphagia and dysphonia durations ranked highly in feature importance assessments.
Insomnia is linked to various comorbidities, necessitating comprehensive treatment approaches.
Clinical Implications
Healthcare providers should consider the duration of dysphagia and dysphonia when assessing patients for insomnia. Incorporating evaluations of swallowing and vocal disorders into insomnia management may enhance treatment outcomes.
Conclusion
The study highlights the importance of recognizing dysphagia and dysphonia as significant risk factors for insomnia, suggesting that addressing these conditions may improve insomnia interventions.
Phones in class, a 25-year prescription gone wrong, pickleball's hidden danger, and why your spin class is too loud — four findings hiding in everyday care.
Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.
